DAPA-RESIST clinical trial - Dapagliflozin versus metolazone in heart failure with diuretic resistance

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Late breaking clinical trials: medical therapy Pharmacotherapy HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by